Khanjan Shah, MD
Interventional Cardiology · Cleveland, OHNPI 1164715116
Payments from drug & device makers
Across 69 payments — averaging $458.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$27K
- Abbott$3K
- Shockwave Medical, Inc$1K
- Teleflex LLC$269
- Terumo Medical Corporation$208
- Canon Medical Systems USA, Inc.$143
- plus $340 from 4 others
What the payments were for
- Consulting fees$4131%
- Speaking & faculty fees$19,45062%
- Travel & lodging$8,51327%
- Food & beverage$3,23910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 26 | $26,834 |
| Abbott | 20 | $2,631 |
| Shockwave Medical, Inc | 8 | $1,189 |
| Teleflex LLC | 2 | $269 |
| Terumo Medical Corporation | 3 | $208 |
| Canon Medical Systems USA, Inc. | 2 | $143 |
| Medtronic | 2 | $138 |
| Inari Medical, Inc. | 1 | $99 |
| Cardiovascular Systems Inc. | 4 | $79 |
| Boston Scientific | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$26,303
- NAVITOR$1,192
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$950
- Xience V coronary stent system$460
- MitraClip$325
- MANTA$269
- Navicross$171
- R2P MISAGO$171
- TR Band$171
- METACROSS OTW$171
- GlideWire$171
- INTERVENTIONAL ANGIOGRAPHY SYSTEM$137
- Endurant$121
- Optis Coronary Imaging System$120
How this compares
$31,614 in reported general payments places this provider in the 70th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $25,781 |
| XareltoRivaroxaban | 19 | $18,345 |
| Atorvastatin Calcium | 57 | $675 |
| Carvedilol | 45 | $471 |
| Cilostazol | 21 | $359 |
| Losartan Potassium | 32 | $334 |
| Rosuvastatin Calcium | 31 | $333 |
| Chlorthalidone | 15 | $207 |
| Metoprolol Succinate | 12 | $188 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 16 | $145 |
| Lisinopril | 30 | $141 |
| Hydrochlorothiazide | 34 | $134 |
| ClopidogrelClopidogrel Bisulfate | 21 | $114 |
| Metoprolol Tartrate | 15 | $80 |
| Furosemide | 17 | $74 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Cleveland
- Jun LiCleveland$634K
- Rishi PuriCleveland$544K
- Khaled ZiadaCleveland$427K
- Grant ReedCleveland$237K
- Rayji TsutsuiCleveland$195K
- Michael ChenierCleveland$122K
- Paul PoommipanitCleveland$101K
- Bernardo CorteseCleveland$100K
- Santiago GarciaCincinnati$3.6M
- Gary AnselColumbus$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.